Biotex, Inc.

HOUSTON, TX 77045
http://www.biotexmedical.com
9 Employees

SBIR Award Summary

Total Number of Awards 68
Total Value of Awards $17.8MM
First Award Date 09/30/97
Most Recent Award Date 09/20/17

Key Personnel

Last Name Name Awards Contact
Ballerstadt Dr. Ralph Ballerstadt 15 Message
Mcnichols Roger J Mcnichols 26
Gowda Ashok Gowda 13 Message
Teferra Seifu Teferra 1
Jackson George W Jackson 15 Message

68 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/20/17 - 03/31/18

Project Summary The overall goal of this SBIR proposal is to develop a novel vaginal stent for use in pediatric and adult populations. There are many girls and women born with congenital gynecologic abnormalities requiring surgical reconstruction of their vaginal cavities. There are also women who have very shortened or scarred vaginas after pel...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 02/01/17 - 01/31/18

? DESCRIPTION (provided by applicant): The goal of this NIH-SBIR Phase II effort is to develop a new point-of-care (POC) detection platform and methodology for assessment of human exposure to hazardous environmental compounds in the bloodstream. Because the mechanisms of transport of such chemicals into the body, their differing stabilities, ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 02/01/16 - 01/31/17

? DESCRIPTION (provided by applicant): The goal of this NIH-SBIR Phase II effort is to develop a new point-of-care (POC) detection platform and methodology for assessment of human exposure to hazardous environmental compounds in the bloodstream. Because the mechanisms of transport of such chemicals into the body, their differing stabilities, ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/01/13 - 08/31/14

DESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to continue development of an exciting platform based on integration of optical coherence tomography acquisition with real-time 3D spatial localization. In Phase I, in the context of gynecological diagnostic imaging, we demonstrated hardware and software for prototype...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/21/12 - 08/31/13

DESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to continue development of an exciting platform based on integration of optical coherence tomography acquisition with real-time 3D spatial localization. In Phase I, in the context of gynecological diagnostic imaging, we demonstrated hardware and software for prototype...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-ES-12-004
Budget: 09/19/12 - 08/31/13

DESCRIPTION (provided by applicant): Project Summary The goal of this NIH-SBIR Phase I proposal is to develop a new point-of-care (POC) detection platform and methodology for assessment of human exposure to hazardous environmental compounds in the bloodstream. Because the mechanisms of transport of such chemicals into the body, their differing s...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-DK-11-018
Budget: 09/15/12 - 08/31/14

DESCRIPTION (provided by applicant): The World Health Organization estimates that diabetes affects about 185 million people worldwide, with approx. 20 million individuals (approx. 6 percent by population) afflicted in the US (approx. 10 percent of this type 1 diabetes). Tighter glucose control within the euglycemic range was shown to be the sing...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-DK-11-018
Budget: 09/15/12 - 08/31/13

DESCRIPTION (provided by applicant): The World Health Organization estimates that diabetes affects about 185 million people worldwide, with approx. 20 million individuals (approx. 6 percent by population) afflicted in the US (approx. 10 percent of this type 1 diabetes). Tighter glucose control within the euglycemic range was shown to be the sing...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 09/01/12 - 08/31/13

DESCRIPTION (provided by applicant): Aptamers have emerged as one of the most promising classes of drug leads and diagnostic ligands presently available. Aptamers, nucleic acid ligands derived from large combinatorial libraries, typically have affinities and specificities that rival antibodies, yet they have a number of significant advantages f...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 06/01/12 - 05/31/13

DESCRIPTION (provided by applicant): The goal of this Phase I SBIR application is to develop a new minimally invasive therapy for laser ablation of epileptogenic seizure foci. There is a large unmet need for better treatment options for the nearly one million epilepsy patients in the U.S. that are refractory to current medical treatments. While ...

Load More